BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30575108)

  • 61. Fluorescence in situ hybridization detection of chromosome IGH/BCL2 translocations from paraffin-embedded tissue: evaluation in follicular lymphoma.
    Hirose Y; Masaki Y; Ozaki M
    Int J Hematol; 2003 Aug; 78(2):154-9. PubMed ID: 12953811
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia.
    Ohno H; Doi S; Yabumoto K; Fukuhara S; McKeithan TW
    Leukemia; 1993 Dec; 7(12):2057-63. PubMed ID: 8255106
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
    Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
    Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
    Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
    Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism.
    Majid A; Tsoulakis O; Walewska R; Gesk S; Siebert R; Kennedy DB; Dyer MJ
    Blood; 2008 Jan; 111(2):874-7. PubMed ID: 17959858
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
    Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature.
    Chapiro E; Radford-Weiss I; Cung HA; Dastugue N; Nadal N; Taviaux S; Barin C; Struski S; Talmant P; Vandenberghe P; Mozziconacci MJ; Tigaud I; Lefebvre C; Penther D; Bastard C; Lippert E; Mugneret F; Romana S; Bernard OA; Harrison CJ; Russell LJ; Nguyen-Khac F;
    Cancer Genet; 2013 May; 206(5):162-73. PubMed ID: 23827691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.
    Del Poeta G; Del Principe MI; Maurillo L; Rossi FM; Buccisano F; Ammatuna E; Simotti C; Zucchetto A; Catalano G; Bulian P; Bruno A; Venditti A; De Fabritiis P; Gattei V; Amadori S
    Leuk Lymphoma; 2010 Jan; 51(1):95-106. PubMed ID: 20001236
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytopathology of "double-hit" non-Hodgkin lymphoma.
    Elkins CT; Wakely PE
    Cancer Cytopathol; 2011 Aug; 119(4):263-71. PubMed ID: 21560252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas.
    Otto C; Scholtysik R; Schmitz R; Kreuz M; Becher C; Hummel M; Rosenwald A; Trümper L; Klapper W; Siebert R; Küppers R;
    Genes Chromosomes Cancer; 2016 Dec; 55(12):932-943. PubMed ID: 27356265
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials.
    Woyach JA
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):476-481. PubMed ID: 31808904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections.
    Espinet B; Bellosillo B; Melero C; Vela MC; Pedro C; Salido M; Pijuan L; Florensa L; Besses C; Serrano S; Solé F
    Leuk Res; 2008 May; 32(5):737-42. PubMed ID: 17964648
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A leukemic double-hit follicular lymphoma associated with a complex variant translocation, t(8;14;18)(q24;q32;q21), involving BCL2, MYC, and IGH.
    Minakata D; Sato K; Ikeda T; Toda Y; Ito S; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Oh I; Fujiwara SI; Ohmine K; Kawata H; Muroi K; Miura I; Kanda Y
    Cancer Genet; 2018 Jan; 220():44-48. PubMed ID: 29310838
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.
    Bacher U; Haferlach T; Schnittger S; Weiss T; Burkhard O; Bechtel B; Kern W; Haferlach C
    Cancer Genet Cytogenet; 2010 Jul; 200(2):170-4. PubMed ID: 20620602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
    Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
    Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Translocation of BCL2 and BCL6 to the same immunoglobulin heavy chain locus in a case of follicular lymphoma.
    Rack K; Delannoy A; Ravoet C; Vannuffel P; Hamels J; Gillerot Y
    Leuk Lymphoma; 2005 Oct; 46(10):1513-6. PubMed ID: 16194898
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events.
    Wlodarska I; Matthews C; Veyt E; Pospisilova H; Catherwood MA; Poulsen TS; Vanhentenrijk V; Ibbotson R; Vandenberghe P; Morris TC; Alexander HD
    J Mol Diagn; 2007 Feb; 9(1):47-54. PubMed ID: 17251335
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
    Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of genetic lesions in apoptosis-regulating and proliferation control genes in diffuse large B-cell non-Hodgkin's lymphoma.
    Pervez S; Nasir MI; Moatter T; Ahsan A; Haq A; Siddiqui T
    J Cancer Res Ther; 2009; 5(4):254-62. PubMed ID: 20160358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.